ScreenerHero

ACW Actinogen Medical Limited

ASX · AU · Healthcare · Biotechnology · actinogen.com.au
—Mkt Cap: —P/E: —

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value102.27M USD
Revenue (TTM)8.76M USD
Gross Profit8.76M USD
Net Income (TTM)-10.63M USD
Revenue/Share0.0040 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000ACW3
Valuation
P/E (Trailing)—
P/E (Forward)-4.30
PEG—
EV/EBITDA-9.80
EV/Revenue11.68
P/S13.14
P/B7.17
EPS (TTM)0.00
EPS (Forward)-0.01
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-37.34%
EBITDA Margin-119.15%
Profit Margin-121.35%
ROE-71.96%
ROA-52.03%
Growth
Revenue Growth96.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.14M USD
CapEx (TTM)6.42K USD
FCF Margin-98.98%
FCF Yield—
Net Debt-8.26M USD
Net Debt/EBITDA0.79
Balance Sheet
Debt/Equity0.22
Current Ratio3.45
Quick Ratio3.44
Book Value/Sh0.0060 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:2
Split DateDec 3, 2013
Analyst Consensus
Rating—
Target (Mean)0.0800 AUD
Target Range0.0800 AUD – 0.0800 AUD
# Analysts1
Ownership
Shares Out.3.87B
Float3.12B
Insiders16.53%
Institutions2.41%
Technical
SMA 500.0512 AUD
SMA 2000.0439 AUD
Beta0.83
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)4.79M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—